Cigna Investments Inc Moderna, Inc. Transaction History

Cigna Investments Inc

$540 Million
Q2 2024

A detailed history of Cigna Investments Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Cigna Investments Inc holds 3,367 shares of MRNA stock, worth $202,693. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,367

Previous 3,497 3.72%

Holding current value

$202,693

Previous $373,000 7.24%

% of portfolio

0.07%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$101.21 - $166.61 $13,157 - $21,659	-130 Reduced 3.72%	3,367 $400,000
Q4 2023 Jan 22, 2024	SELL	$69.51 - $104.43 $5,491 - $8,249	-79 Reduced 2.21%	3,497 $348,000
Q3 2023 Oct 23, 2023	SELL	$96.41 - $126.61 $44,348 - $58,240	-460 Reduced 11.4%	3,576 $369,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $13,159 - $19,110	-97 Reduced 2.35%	4,036 $620,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $5,682 - $10,081	-48 Reduced 1.15%	4,133 $743,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $32,351 - $53,205	-274 Reduced 6.15%	4,181 $494,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $191,039 - $288,018	-1,631 Reduced 26.8%	4,455 $637,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $234,456 - $435,782	-1,854 Reduced 23.35%	6,086 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $646,071 - $1.05 Million	-2,861 Reduced 26.49%	7,940 $2.02 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.84 Million - $4.01 Million	8,276 Added 327.76%	10,801 $4.16 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $42,740 - $77,308	329 Added 14.98%	2,525 $594,000
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $55,026 - $93,733	-504 Reduced 18.67%	2,196 $287,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $177,498 - $458,622	2,700 New	2,700 $282,000

Others Institutions Holding MRNA

# of Institutions

1,112

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Account

Cigna Investments Inc Moderna, Inc. Transaction History